Stock HTGC HERCULES CAPITAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Hercules Capital, Inc.

Equities

HTGC

US4270965084

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-17 pm EDT 		5-day change 1st Jan Change
19.36 USD +1.52% Intraday chart for Hercules Capital, Inc. -2.71% +16.14%
May. 17 UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating MT
May. 15 Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hercules Capital : 2025 Proxy Statement
PU
UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating
MT
Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital
MT
Hercules Capital Announces Date of 2024 Annual Meeting of Stockholders
BU
Ex-dividend day
FA
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
AQ
Electric Hydrogen secures $100M credit facility from HSBC, J.P. Morgan, Stifel Bank and Hercules Capital to decarbonize critical industries at scale
AQ
X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise
MT
Verona Pharma Signs Financing Agreements for Up to $650 Million
MT
X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
AQ
Hercules Capital Announces Upcoming Event for the Financial Community
BU
Transcript : Hercules Capital, Inc., Q1 2024 Earnings Call, May 02, 2024
Hercules Capital: Q1 Earnings Snapshot
AQ
Hercules Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Hercules Capital Reports First Quarter 2024 Financial Results
BU
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024
BU
Hercules Capital, Inc. Declares First Quarter Cash Dividend, Payable on May 14, 2024
CI
Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment
MT
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations
BU
Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HTGC Stock
  4. News Hercules Capital, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW